Abstract: The invention describes a process for the manufacture of a gas diffusion electrode involving preparing a powder mixture containing at least a catalyst and a binder, applying the powder mixture to an electrically conducting support, and pressing the powder mixture with the electrically conducting support.

Abstract: The invention relates to nonadepsipeptides and processes for their preparation, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.

Abstract: The invention provides a human DRD4 which is associated with the cardiovascular disorders, gastrointestinal and liver diseases, hematological disorders, neurological disorders and respiratory diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, gastrointestinal and liver diseases, hematological disorders, neurological disorders and respiratory diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of DRD4 as well as pharmaceutical compositions comprising such compounds.

Abstract: The present invention relates to a compound of the formula (I) and/or salts thereof in which R is a hydrocarbon radical or hydrocarbonoxy radical, which is unsubstituted or substituted and inclusive of substituents has 1 to 30 carbon atoms, or is a heterocyclyl radical or heterocyclyloxy radical which is unsubstituted or substituted, or R is a radical OC(O)R3, S(O)nR3, OS(O)nR3, F, Br, I, OH, CN, NO2, NH2, SF5, NR4R5 or Si(R6)3, where n is 0, 1 or 2, R1 independently at each occurrence is halogen, OH, SH, a carbon-free, nitrogen-containing radical or a carbon-containing radical which has 1 to 30 carbon atoms, or R0 and R# form with one another a nitrogen-containing heterocyclic ring, I is 0, 1, 2 or 3, R2 is a hydrogen atom or a hydrocarbon radical which is unsubstituted or substituted and inclusive of substituents has 1 to 20 carbon atoms, R3 is a hydrocarbon radical or hydrocarbonoxy radical which is unsubstituted or substituted and inclusive of substituents has 1 to 30 carbon atoms, or is a het

Abstract: The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) from Acinetobacter and to a process for their preparation by overexpression in suitable microbial expression systems.

Abstract: A continuous process for mixing polymer melts with additives, in particular polycarbonate melts with additives in liquid form, in solution or in dispersion is described. The additives are added to a main stream of polymer melt and are then mixed, preferably directly, with the main stream in a static mixer.

Abstract: In a process for the quantitative optical analysis of biological cells labelled with a fluorescent dye, the sensitivity of analytical detection can be considerably improved if a masking dye, which absorbs the excitation light for the fluorescent dye and/or its emission light is added to the solution surrounding the biological cells and/or if a separating layer permeable to the solution and absorbing and/or reflecting the excitation light or the emission light is applied to a layer of the biological cells at the bottom of a reaction vessel. This process can also be used for improving the sensitivity in the quantitative optical analysis of a luminescent biological cell layer. Analogously, these process principles can also be used in receptor studies for the masking of the interfering background radiation in the quantitative optical analysis of fluorescently or luminescently labelled reaction components.

Abstract: The invention relates to novel 1-aza-bicyclic N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.

Abstract: A thermoplastic molding composition comprising polyamide is disclosed. The composition that contains vinyl (co)polymer and an optional solvent is useful in application where inhibited crystallization of polyamide is desirable, including laser-welding.

Abstract: The invention relates to an installation and a process for the production of foam in a continuous block foam process in which the height of a foam-forming mixture along a conveyor is measured and a correcting variable as a function of deviation of the actual height risen from the standard height is determined.

Abstract: This invention relates to tetrahydro-naphthalene derivatives and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The tetrahydro-naphthalene derivatives of the present invention have an excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, incontinence, inflammatory disorders such as asthma and COPD.

Abstract: The invention provides a human AHR which is associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, respiratory diseases, urological diseases and gastroenterological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, respiratory diseases, urological diseases and gastroenterological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of AHR as well as pharmaceutical compositions comprising such compounds.

Abstract: Sulfonylamino(thio)carbonyl compounds are used to control unwanted plants or to regulate growth in plants. Sulfonylamino(thio)carbonyl compounds are applied to plants, the seed or the area on which the plants are growing to control the growth of such plants.

Abstract: A composition containing a graft polymer based on acrylonitrile/ethylene propylene rubber/styrene (AES) and an additive is disclosed. The additive is one which increases the “?soft phase” of the composition making it possible to produce moldings with improved toughness at low temperatures, without substantially changing the melt volume rate.

Abstract: This application relates to compounds of formula (I), wherein R1, R2, R3, and R4 are defined as recited in the claims, or a tautomer, salt, hydrate, or alkoxide thereof. A process for preparing such materials, pharmaceutical compositions containing them, and methods of treating a cardiovascular disorder by administering them to a patient are also disclosed and claimed.

Abstract: This application relates to compounds of the formula (I) in which R1 is chlorine, cyano, trifluoromethyl or methoxy and R2 is hydrogen or flurorine; or R1 and R2 are both fluorine; and to pharmaceutically acceptable salts of these materials. Pharmaceutical compositions containing these materials, and methods of using them in treatment of hypertension and sexual dysfunction are also disclosed and claimed.

Abstract: The present invention relates to crosslinked rubber particles modified by secondary amino-(meth)-acrylate groups, a process for their production, their use for the production of rubber vulcanizates or rubber molded bodies of all kinds and also the rubber vulcanizates or rubber molded bodies that can be obtained from the rubber particles.

Abstract: The present invention relates to novel insecticidally and acaricidally active compound combinations of N2-[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide of the formula (I) and active compounds identified in the disclosure.

Abstract: A radiation curable coating composition that includes from about 5 to about 70% by weight of the reaction product of i) one or more polyisocyanates, where at least 10 equivalent percent of the isocyanate groups are in the form of uretdione groups, and ii) one or more hydroxy functional lactone ester (meth)acrylates. The amount of component i), on an isocyanate equivalent basis, is equal to the amount of hydroxy equivalents of hydroxy containing materials in the composition. The composition can be used to coat substrates by coating at least a portion of the substrate with the above-described coating composition and subjecting the coated substrate to radiation.

Abstract: The present invention relates to plant cells and plants, which are genetically modified, wherein the genetic modification leads to the reduction of the activity of a Class 3 vegetable branching enzyme in comparison with corresponding wild type plant cells or wild type plants that have not been genetically modified. Furthermore, the present invention relates to means and methods for the manufacture of such plant cells and plants. Plant cells and plants of this type synthesise a modified starch. The present invention therefore also relates to the starch synthesised by the plant cells and plants according to the invention as well as to methods for the manufacture of the starch and to the manufacture of starch derivatives of this starch. Furthermore, the present invention relates to nucleic acids coding a Class 3 branching enzyme, vectors, host cells, plant cells and plants containing such nucleic acid molecules.